Therefore, achieving critical levels of RS in the tumor is another rationale for the strategy of “accelerating” the cell cycle by targeting the DNA damage checkpoints including CHK1 (targeting the checkpoint to kill cancer cells is reviewed in [88]). The gene discussed is CHEK1; the disease is neoplasm.